A股異動丨恆泰艾普(300157.SZ)大漲逾9% 獲股東李麗萍增持1.01%股份
格隆匯8月13日丨恆泰艾普(300157.SZ)盤中曾幾度漲停創6個月新高,現報4.15元,漲9.21%,暫成交1.59億元,最新總市值29.5億元。恆泰艾普公佈,股東李麗萍於2020年8月11日通過證券交易所的集中交易累計增持718.91萬股,增持比例1.01%。此次增持後,李麗萍持有股份3337.82萬股,比例達4.69%。值得一提的是,8月11日晚深交所向恆泰艾普發出關注函,要求公司詳細説明本次修訂《公司章程》的原因、背景等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.